商品标签为:'洛沙坦'
浏览为
排序由
显示 每页
氯沙坦 [洛沙坦],Losartan;≥98% (HPLC)
SML3317
别名:2-丁基-4-氯-1-[[2′-(1H-四唑-5-基)-1,1′-联苯-4-基]甲基]-1H-咪唑-5-甲基;1-[1-[2′-(2H-四唑-5-基)联苯-4-基]甲基]-2-丁基-4-氯-1H-咪唑-5-基]甲醇;2-丁基-4-氯-1-[[2′-(2H-四唑-5-基)[1,1′-联苯]-4-基]甲基]-1H-咪唑-5-乙醇;2-Butyl-4-chloro-1-[[2′-(1H-tetrazol-5-yl)-1,1′-biphenyl-4-yl]methyl]-1H-imidazole-5-methanol, 1-[1-[[2′-(2H-Tetrazol-5-yl)biphenyl-4-yl]methyl]-2-butyl-4-chloro-1H-imidazol-5-yl]methanol, 2-Butyl-4-chloro-1-[[2′-(2H-tetrazol-5-yl)[1,1′-biphenyl]-4-yl]methyl]-1H-imidazole-5-methanol, DUP 89
Empirical Formula (Hill Notation): C22H23ClN6O CAS号: 114798-26-4 分子量: 422.91 MDL编号: MFCD19686114
Empirical Formula (Hill Notation): C22H23ClN6O CAS号: 114798-26-4 分子量: 422.91 MDL编号: MFCD19686114
氯沙坦 [洛沙坦],Losartan;≥97.0%
L14754
别名:2-丁基-4-氯-1-[[2′-(1H-四唑-5-基)-1,1′-联苯-4-基]甲基]-1H-咪唑-5-甲基;1-[1-[2′-(2H-四唑-5-基)联苯-4-基]甲基]-2-丁基-4-氯-1H-咪唑-5-基]甲醇;2-丁基-4-氯-1-[[2′-(2H-四唑-5-基)[1,1′-联苯]-4-基]甲基]-1H-咪唑-5-乙醇;2-Butyl-4-chloro-1-[[2′-(1H-tetrazol-5-yl)-1,1′-biphenyl-4-yl]methyl]-1H-imidazole-5-methanol, 1-[1-[[2′-(2H-Tetrazol-5-yl)biphenyl-4-yl]methyl]-2-butyl-4-chloro-1H-imidazol-5-yl]methanol, 2-Butyl-4-chloro-1-[[2′-(2H-tetrazol-5-yl)[1,1′-biphenyl]-4-yl]methyl]-1H-imidazole-5-methanol, DUP 89
Empirical Formula (Hill Notation): C22H23ClN6O CAS号: 114798-26-4 分子量: 422.91 MDL编号: MFCD19686114
Empirical Formula (Hill Notation): C22H23ClN6O CAS号: 114798-26-4 分子量: 422.91 MDL编号: MFCD19686114
最近浏览商品
-
氰基乙酸甲酯,Methyl cyanoacetate;99% -
磷酸三钙,Tricalcium phosphate;powder, 4 μm, ≥80 m2g -
199培养基 [M199培养基],Medium 199;HEPES Modification, with Earle′s salts, 25 mM HEPES and sodium bicarbonate, without L-glutamine, liquid, sterile-filtered, suitable for cell culture -
印楝素,Azadirachtin;~95% -
乙酸钙水合物,Calcium acetate hydrate;ReagentPlus®, ≥99% (titration), powder -
L-胱氨酸,L-Cystine;≥98% (TLC), crystalline
